All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
18Apr19 07:00 RNS-R AGL:LON ANGLE plc Health £32.6m Parsortix used in new cancer assessment technique
12Apr19 07:00 RNS-R AGL:LON ANGLE plc Health £32.6m LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00 RNS AGL:LON ANGLE plc Health £32.6m AACR 2019
11Mar19 07:00 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
07Mar19 07:00 RNS AGL:LON ANGLE plc Health £32.6m ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00 RNS AGL:LON ANGLE plc Health £32.6m FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00 RNS AGL:LON ANGLE plc Health £32.6m CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00 RNS AGL:LON ANGLE plc Health £32.6m Research into role of immune cells in cancer
31Jan19 07:00 RNS AGL:LON ANGLE plc Health £32.6m Interim Results
29Jan19 07:00 RNS-R AGL:LON ANGLE plc Health £32.6m NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01 RNS AGL:LON ANGLE plc Health £32.6m BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00 RNS AGL:LON ANGLE plc Health £32.6m Notice of Results
21Dec18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Issue of LTIP Options and Share Options
28Nov18 07:00 RNS-R AGL:LON ANGLE plc Health £32.6m LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
05Nov18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Acquisition of outstanding shares
01Nov18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Appointment of Dr Jan Groen as NED
30Oct18 16:21 RNS AGL:LON ANGLE plc Health £32.6m Result of AGM
29Oct18 07:00 RNS AGL:LON ANGLE plc Health £32.6m PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Good Progress with FDA Studies
09Oct18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Notice of AGM
25Jul18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Preliminary Results for year ended 30 April 2018
24Jul18 17:42 RNS AGL:LON ANGLE plc Health £32.6m EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34 RNS AGL:LON ANGLE plc Health £32.6m Result of General Meeting
02Jul18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Notice of Preliminary Results
25Jun18 18:20 RNS AGL:LON ANGLE plc Health £32.6m Results of Fundraising
25Jun18 14:58 RNS AGL:LON ANGLE plc Health £32.6m Close of Accelerated Bookbuild
25Jun18 07:50 RNS AGL:LON ANGLE plc Health £32.6m Proposed Placing of New Ordinary Shares
04Jun18 07:00 RNS AGL:LON ANGLE plc Health £32.6m ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Breakthrough Research with Parsortix
05Apr18 07:00 RNS AGL:LON ANGLE plc Health £32.6m First patient enrolled in FDA study
26Mar18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Research Update
06Feb18 07:00 RNS AGL:LON ANGLE plc Health £32.6m ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00 RNS AGL:LON ANGLE plc Health £32.6m Interim Results
10Jan18 10:16 RNS AGL:LON ANGLE plc Health £32.6m Notice of Results
08Jan18 07:00 RNS AGL:LON ANGLE plc Health £32.6m ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
12Dec17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Transfer of Lock-in Shares
08Dec17 07:00 RNS AGL:LON ANGLE plc Health £32.6m PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00 RNS AGL:LON ANGLE plc Health £32.6m PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
16Nov17 08:23 RNS AGL:LON ANGLE plc Health £32.6m Total Voting Rights and Covington Subscription
06Nov17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
06Nov17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
06Nov17 07:00 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
02Nov17 10:04 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
01Nov17 08:12 RNS AGL:LON ANGLE plc Health £32.6m ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18 RNS AGL:LON ANGLE plc Health £32.6m Result of AGM
30Oct17 10:31 RNS AGL:LON ANGLE plc Health £32.6m Result of General Meeting
26Oct17 08:10 RNS AGL:LON ANGLE plc Health £32.6m Total Voting Rights
23Oct17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix harvests cancer cells from bone marrow
20Oct17 15:05 RNS AGL:LON ANGLE plc Health £32.6m Notice of AGM
12Oct17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Proposed further subscription for £2.8 million
09Oct17 07:02 RNS AGL:LON ANGLE plc Health £32.6m CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01 RNS AGL:LON ANGLE plc Health £32.6m Potential new analytical protocol using Parsortix
05Oct17 11:46 RNS AGL:LON ANGLE plc Health £32.6m Results of Fundraising
05Oct17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Acquisition and Fundraising
13Sep17 17:36 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
13Sep17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Co-Marketing Partnership with QIAGEN
05Sep17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Change of Adviser
27Jul17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Preliminary Results
06Jul17 10:05 RNS AGL:LON ANGLE plc Health £32.6m Notice of Results
04Jul17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix breakthrough in prostate cancer
03May17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Business Update
04Apr17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
03Apr17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix enables analysis in head and neck cancer
30Mar17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Prostate Cancer Update
14Feb17 11:39 EQS AGL:LON ANGLE plc Health £32.6m Edison issues outlook on Angle
26Jan17 07:01 RNS AGL:LON ANGLE plc Health £32.6m Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Interim Results
04Jan17 07:00 RNS AGL:LON ANGLE plc Health £32.6m Notice of Results
28Nov16 07:00 RNS AGL:LON ANGLE plc Health £32.6m ISSUE OF SHARE OPTIONS
24Nov16 14:48 RNS AGL:LON ANGLE plc Health £32.6m Result of GM
04Nov16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Barts Research Supports Potential Use of Parsortix
01Nov16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Notice of GM
27Oct16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Director's share purchase
07Oct16 11:57 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
04Oct16 16:35 RNS AGL:LON ANGLE plc Health £32.6m Result of AGM
30Sep16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Research published in Clinical Chemistry
19Sep16 11:14 RNS AGL:LON ANGLE plc Health £32.6m Issue of Equity
09Sep16 16:12 RNS AGL:LON ANGLE plc Health £32.6m Annual Report and Accounts and Notice of AGM
27Jul16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Initiation of European ovarian cancer study
15Jul16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Notice of Results
15Jul16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix gaining traction at EACR Conference
01Jun16 15:04 RNS AGL:LON ANGLE plc Health £32.6m Holding(s) in Company
31May16 16:36 RNS LGEN:LON, AGL:LON ANGLE plc, Legal & General Group Plc Various Various Holding(s) in Company
25May16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Placing
25May16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Cancer Research UK Contract
18Apr16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix potential in metastatic breast cancer
21Mar16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix potential for prostate cancer detection
09Mar16 07:00 RNS AGL:LON ANGLE plc Health £32.6m European patent grant for Parsortix
28Jan16 07:00 RNS AGL:LON ANGLE plc Health £32.6m Interim Results
27Jan16 10:42 RNS AGL:LON ANGLE plc Health £32.6m Notice of Interim Results
25Jan16 07:00 RNS AGL:LON ANGLE plc Health £32.6m UKE publishes evaluation of Parsortix
22Dec15 07:00 RNS AGL:LON ANGLE plc Health £32.6m Completion of Geomerics Transaction
15Dec15 07:00 RNS AGL:LON ANGLE plc Health £32.6m Parsortix first commercial sales
30Nov15 17:56 RNS AGL:LON, 0RPW:LON ANGLE plc, Janus Henderson Group PLC Various Various Holding(s) in Company
Date / Time Source Company % Chg
18Apr19 07:00 RNS-R ANGLE plc 2.04%
Parsortix used in new cancer assessment technique
12Apr19 07:00 RNS-R ANGLE plc 2.04%
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00 RNS ANGLE plc 2.04%
AACR 2019
11Mar19 07:00 RNS ANGLE plc, Legal & General Group Plc -0.19%
Holding(s) in Company
07Mar19 07:00 RNS ANGLE plc 2.04%
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00 RNS ANGLE plc 2.04%
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00 RNS ANGLE plc 2.04%
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00 RNS ANGLE plc 2.04%
Research into role of immune cells in cancer
31Jan19 07:00 RNS ANGLE plc 2.04%
Interim Results
29Jan19 07:00 RNS-R ANGLE plc 2.04%
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01 RNS ANGLE plc 2.04%
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00 RNS ANGLE plc 2.04%
Notice of Results
21Dec18 07:00 RNS ANGLE plc 2.04%
Issue of LTIP Options and Share Options
28Nov18 07:00 RNS-R ANGLE plc 2.04%
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10 RNS ANGLE plc 2.04%
Holding(s) in Company
05Nov18 07:00 RNS ANGLE plc 2.04%
Acquisition of outstanding shares
01Nov18 07:00 RNS ANGLE plc 2.04%
Appointment of Dr Jan Groen as NED
30Oct18 16:21 RNS ANGLE plc 2.04%
Result of AGM
29Oct18 07:00 RNS ANGLE plc 2.04%
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00 RNS ANGLE plc 2.04%
Good Progress with FDA Studies
09Oct18 07:00 RNS ANGLE plc 2.04%
Notice of AGM
25Jul18 07:00 RNS ANGLE plc 2.04%
Preliminary Results for year ended 30 April 2018
24Jul18 17:42 RNS ANGLE plc 2.04%
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34 RNS ANGLE plc 2.04%
Result of General Meeting
02Jul18 07:00 RNS ANGLE plc 2.04%
Notice of Preliminary Results
25Jun18 18:20 RNS ANGLE plc 2.04%
Results of Fundraising
25Jun18 14:58 RNS ANGLE plc 2.04%
Close of Accelerated Bookbuild
25Jun18 07:50 RNS ANGLE plc 2.04%
Proposed Placing of New Ordinary Shares
04Jun18 07:00 RNS ANGLE plc 2.04%
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00 RNS ANGLE plc 2.04%
Breakthrough Research with Parsortix
05Apr18 07:00 RNS ANGLE plc 2.04%
First patient enrolled in FDA study
26Mar18 07:00 RNS ANGLE plc 2.04%
Research Update
06Feb18 07:00 RNS ANGLE plc 2.04%
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00 RNS ANGLE plc 2.04%
Interim Results
10Jan18 10:16 RNS ANGLE plc 2.04%
Notice of Results
08Jan18 07:00 RNS ANGLE plc 2.04%
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49 RNS ANGLE plc 2.04%
Holding(s) in Company
12Dec17 07:00 RNS ANGLE plc 2.04%
Transfer of Lock-in Shares
08Dec17 07:00 RNS ANGLE plc 2.04%
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00 RNS ANGLE plc 2.04%
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06 RNS ANGLE plc 2.04%
Holding(s) in Company
16Nov17 08:23 RNS ANGLE plc 2.04%
Total Voting Rights and Covington Subscription
06Nov17 07:00 RNS ANGLE plc 2.04%
Holding(s) in Company
06Nov17 07:00 RNS ANGLE plc 2.04%
Holding(s) in Company
06Nov17 07:00 RNS ANGLE plc, Legal & General Group Plc -0.19%
Holding(s) in Company
02Nov17 10:04 RNS ANGLE plc 2.04%
Holding(s) in Company
01Nov17 08:12 RNS ANGLE plc 2.04%
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18 RNS ANGLE plc 2.04%
Result of AGM
30Oct17 10:31 RNS ANGLE plc 2.04%
Result of General Meeting
26Oct17 08:10 RNS ANGLE plc 2.04%
Total Voting Rights
23Oct17 07:00 RNS ANGLE plc 2.04%
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05 RNS ANGLE plc 2.04%
Notice of AGM
12Oct17 07:00 RNS ANGLE plc 2.04%
Proposed further subscription for £2.8 million
09Oct17 07:02 RNS ANGLE plc 2.04%
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01 RNS ANGLE plc 2.04%
Potential new analytical protocol using Parsortix
05Oct17 11:46 RNS ANGLE plc 2.04%
Results of Fundraising
05Oct17 07:00 RNS ANGLE plc 2.04%
Acquisition and Fundraising
13Sep17 17:36 RNS ANGLE plc 2.04%
Holding(s) in Company
13Sep17 07:00 RNS ANGLE plc 2.04%
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00 RNS ANGLE plc 2.04%
Co-Marketing Partnership with QIAGEN
05Sep17 07:00 RNS ANGLE plc 2.04%
Change of Adviser
27Jul17 07:00 RNS ANGLE plc 2.04%
Preliminary Results
06Jul17 10:05 RNS ANGLE plc 2.04%
Notice of Results
04Jul17 07:00 RNS ANGLE plc 2.04%
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00 RNS ANGLE plc 2.04%
Parsortix breakthrough in prostate cancer
03May17 07:00 RNS ANGLE plc 2.04%
Business Update
04Apr17 07:00 RNS ANGLE plc 2.04%
Holding(s) in Company
03Apr17 07:00 RNS ANGLE plc 2.04%
Parsortix enables analysis in head and neck cancer
30Mar17 07:00 RNS ANGLE plc 2.04%
Prostate Cancer Update
14Feb17 11:39 EQS ANGLE plc 2.04%
Edison issues outlook on Angle
26Jan17 07:01 RNS ANGLE plc 2.04%
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00 RNS ANGLE plc 2.04%
Interim Results
04Jan17 07:00 RNS ANGLE plc 2.04%
Notice of Results
28Nov16 07:00 RNS ANGLE plc 2.04%
ISSUE OF SHARE OPTIONS
24Nov16 14:48 RNS ANGLE plc 2.04%
Result of GM
04Nov16 07:00 RNS ANGLE plc 2.04%
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00 RNS ANGLE plc 2.04%
Notice of GM
27Oct16 07:00 RNS ANGLE plc 2.04%
Director's share purchase
07Oct16 11:57 RNS ANGLE plc, Legal & General Group Plc -0.19%
Holding(s) in Company
04Oct16 16:35 RNS ANGLE plc 2.04%
Result of AGM
30Sep16 07:00 RNS ANGLE plc 2.04%
Research published in Clinical Chemistry
19Sep16 11:14 RNS ANGLE plc 2.04%
Issue of Equity
09Sep16 16:12 RNS ANGLE plc 2.04%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00 RNS ANGLE plc 2.04%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 RNS ANGLE plc 2.04%
Initiation of European ovarian cancer study
15Jul16 07:00 RNS ANGLE plc 2.04%
Notice of Results
15Jul16 07:00 RNS ANGLE plc 2.04%
Parsortix gaining traction at EACR Conference
01Jun16 15:04 RNS ANGLE plc 2.04%
Holding(s) in Company
31May16 16:36 RNS ANGLE plc, Legal & General Group Plc -0.19%
Holding(s) in Company
25May16 07:00 RNS ANGLE plc 2.04%
Placing
25May16 07:00 RNS ANGLE plc 2.04%
Cancer Research UK Contract
18Apr16 07:00 RNS ANGLE plc 2.04%
Parsortix potential in metastatic breast cancer
21Mar16 07:00 RNS ANGLE plc 2.04%
Parsortix potential for prostate cancer detection
09Mar16 07:00 RNS ANGLE plc 2.04%
European patent grant for Parsortix
28Jan16 07:00 RNS ANGLE plc 2.04%
Interim Results
27Jan16 10:42 RNS ANGLE plc 2.04%
Notice of Interim Results
25Jan16 07:00 RNS ANGLE plc 2.04%
UKE publishes evaluation of Parsortix
22Dec15 07:00 RNS ANGLE plc 2.04%
Completion of Geomerics Transaction
15Dec15 07:00 RNS ANGLE plc 2.04%
Parsortix first commercial sales
30Nov15 17:56 RNS ANGLE plc, Janus Henderson Group PLC 2.04%
Holding(s) in Company
Date / Time Company % Chg
18Apr19 07:00 ANGLE plc 2.04%
Parsortix used in new cancer assessment technique
12Apr19 07:00 ANGLE plc 2.04%
LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM
04Apr19 07:00 ANGLE plc 2.04%
AACR 2019
11Mar19 07:00 AGL LSE,LGEN LSE -0.19%
Holding(s) in Company
07Mar19 07:00 ANGLE plc 2.04%
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28Feb19 07:00 ANGLE plc 2.04%
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25Feb19 07:00 ANGLE plc 2.04%
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11Feb19 07:00 ANGLE plc 2.04%
Research into role of immune cells in cancer
31Jan19 07:00 ANGLE plc 2.04%
Interim Results
29Jan19 07:00 ANGLE plc 2.04%
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
10Jan19 16:01 ANGLE plc 2.04%
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09Jan19 07:00 ANGLE plc 2.04%
Notice of Results
21Dec18 07:00 ANGLE plc 2.04%
Issue of LTIP Options and Share Options
28Nov18 07:00 ANGLE plc 2.04%
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13Nov18 17:10 ANGLE plc 2.04%
Holding(s) in Company
05Nov18 07:00 ANGLE plc 2.04%
Acquisition of outstanding shares
01Nov18 07:00 ANGLE plc 2.04%
Appointment of Dr Jan Groen as NED
30Oct18 16:21 ANGLE plc 2.04%
Result of AGM
29Oct18 07:00 ANGLE plc 2.04%
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25Oct18 07:00 ANGLE plc 2.04%
Good Progress with FDA Studies
09Oct18 07:00 ANGLE plc 2.04%
Notice of AGM
25Jul18 07:00 ANGLE plc 2.04%
Preliminary Results for year ended 30 April 2018
24Jul18 17:42 ANGLE plc 2.04%
EIS/VCT Advance Assurance and Total Voting Rights
18Jul18 10:34 ANGLE plc 2.04%
Result of General Meeting
02Jul18 07:00 ANGLE plc 2.04%
Notice of Preliminary Results
25Jun18 18:20 ANGLE plc 2.04%
Results of Fundraising
25Jun18 14:58 ANGLE plc 2.04%
Close of Accelerated Bookbuild
25Jun18 07:50 ANGLE plc 2.04%
Proposed Placing of New Ordinary Shares
04Jun18 07:00 ANGLE plc 2.04%
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
19Apr18 07:00 ANGLE plc 2.04%
Breakthrough Research with Parsortix
05Apr18 07:00 ANGLE plc 2.04%
First patient enrolled in FDA study
26Mar18 07:00 ANGLE plc 2.04%
Research Update
06Feb18 07:00 ANGLE plc 2.04%
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31Jan18 07:00 ANGLE plc 2.04%
Interim Results
10Jan18 10:16 ANGLE plc 2.04%
Notice of Results
08Jan18 07:00 ANGLE plc 2.04%
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27Dec17 11:49 ANGLE plc 2.04%
Holding(s) in Company
12Dec17 07:00 ANGLE plc 2.04%
Transfer of Lock-in Shares
08Dec17 07:00 ANGLE plc 2.04%
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER
23Nov17 07:00 ANGLE plc 2.04%
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17Nov17 16:06 ANGLE plc 2.04%
Holding(s) in Company
16Nov17 08:23 ANGLE plc 2.04%
Total Voting Rights and Covington Subscription
06Nov17 07:00 ANGLE plc 2.04%
Holding(s) in Company
06Nov17 07:00 ANGLE plc 2.04%
Holding(s) in Company
06Nov17 07:00 AGL LSE,LGEN LSE -0.19%
Holding(s) in Company
02Nov17 10:04 ANGLE plc 2.04%
Holding(s) in Company
01Nov17 08:12 ANGLE plc 2.04%
ANGLE: Completion of Fundraising and Acquisition
31Oct17 14:18 ANGLE plc 2.04%
Result of AGM
30Oct17 10:31 ANGLE plc 2.04%
Result of General Meeting
26Oct17 08:10 ANGLE plc 2.04%
Total Voting Rights
23Oct17 07:00 ANGLE plc 2.04%
Parsortix harvests cancer cells from bone marrow
20Oct17 15:05 ANGLE plc 2.04%
Notice of AGM
12Oct17 07:00 ANGLE plc 2.04%
Proposed further subscription for £2.8 million
09Oct17 07:02 ANGLE plc 2.04%
CTCs harvested with Parsortix grown in laboratory
09Oct17 07:01 ANGLE plc 2.04%
Potential new analytical protocol using Parsortix
05Oct17 11:46 ANGLE plc 2.04%
Results of Fundraising
05Oct17 07:00 ANGLE plc 2.04%
Acquisition and Fundraising
13Sep17 17:36 ANGLE plc 2.04%
Holding(s) in Company
13Sep17 07:00 ANGLE plc 2.04%
Exclusive worldwide option over megakaryocyte IP
11Sep17 07:00 ANGLE plc 2.04%
Co-Marketing Partnership with QIAGEN
05Sep17 07:00 ANGLE plc 2.04%
Change of Adviser
27Jul17 07:00 ANGLE plc 2.04%
Preliminary Results
06Jul17 10:05 ANGLE plc 2.04%
Notice of Results
04Jul17 07:00 ANGLE plc 2.04%
Successful Headline Data in Ovarian Cancer Studies
15Jun17 07:00 ANGLE plc 2.04%
Parsortix breakthrough in prostate cancer
03May17 07:00 ANGLE plc 2.04%
Business Update
04Apr17 07:00 ANGLE plc 2.04%
Holding(s) in Company
03Apr17 07:00 ANGLE plc 2.04%
Parsortix enables analysis in head and neck cancer
30Mar17 07:00 ANGLE plc 2.04%
Prostate Cancer Update
14Feb17 11:39 ANGLE plc 2.04%
Edison issues outlook on Angle
26Jan17 07:01 ANGLE plc 2.04%
Interim Evaluation of Ovarian Cancer Study
26Jan17 07:00 ANGLE plc 2.04%
Interim Results
04Jan17 07:00 ANGLE plc 2.04%
Notice of Results
28Nov16 07:00 ANGLE plc 2.04%
ISSUE OF SHARE OPTIONS
24Nov16 14:48 ANGLE plc 2.04%
Result of GM
04Nov16 07:00 ANGLE plc 2.04%
Barts Research Supports Potential Use of Parsortix
01Nov16 07:00 ANGLE plc 2.04%
Notice of GM
27Oct16 07:00 ANGLE plc 2.04%
Director's share purchase
07Oct16 11:57 AGL LSE,LGEN LSE -0.19%
Holding(s) in Company
04Oct16 16:35 ANGLE plc 2.04%
Result of AGM
30Sep16 07:00 ANGLE plc 2.04%
Research published in Clinical Chemistry
19Sep16 11:14 ANGLE plc 2.04%
Issue of Equity
09Sep16 16:12 ANGLE plc 2.04%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00 ANGLE plc 2.04%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 ANGLE plc 2.04%
Initiation of European ovarian cancer study
15Jul16 07:00 ANGLE plc 2.04%
Notice of Results
15Jul16 07:00 ANGLE plc 2.04%
Parsortix gaining traction at EACR Conference
01Jun16 15:04 ANGLE plc 2.04%
Holding(s) in Company
31May16 16:36 AGL LSE,LGEN LSE -0.19%
Holding(s) in Company
25May16 07:00 ANGLE plc 2.04%
Placing
25May16 07:00 ANGLE plc 2.04%
Cancer Research UK Contract
18Apr16 07:00 ANGLE plc 2.04%
Parsortix potential in metastatic breast cancer
21Mar16 07:00 ANGLE plc 2.04%
Parsortix potential for prostate cancer detection
09Mar16 07:00 ANGLE plc 2.04%
European patent grant for Parsortix
28Jan16 07:00 ANGLE plc 2.04%
Interim Results
27Jan16 10:42 ANGLE plc 2.04%
Notice of Interim Results
25Jan16 07:00 ANGLE plc 2.04%
UKE publishes evaluation of Parsortix
22Dec15 07:00 ANGLE plc 2.04%
Completion of Geomerics Transaction
15Dec15 07:00 ANGLE plc 2.04%
Parsortix first commercial sales
30Nov15 17:56 AGL LSE,HGG LSE 2.04%
Holding(s) in Company